New enrollees in healthcare exchanges to pay higher drug costs
December 20th 2013The newly enrolled individuals in the healthcare exchanges will be faced with higher out-of-pocket costs for their medications than those who receive insurance through their employers, according to an analysis by Avalere Health of more than 600 health plans in the exchanges.
First once-daily dual bronchodilator for COPD approved
December 20th 2013FDA approved umeclidinium and vilanterol inhalation powder (Anoro Ellipta, GlaxoSmithKline and Theravance) for the once-daily, long-term maintenance treatment of airflow obstruction in patients with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and/or emphysema.
Amneal launches delayed-release proton pump inhibitor for GERD
December 17th 2013Amneal Pharmaceuticals will start shipping its branded Esomeprazole Strontium 49.3 mg delayed-release capsules on December 18 to three major U.S. wholesalers. Its capsules contain the same active ingredient, esomeprazole, in a different salt form, as found in Nexium (esomeprazole magnesium).